These compounds include molecules targeting programmed cell death receptor-1 (PD-1) or its ligand (PD-L1) as well as cytotoxic T-lymphocyte antigen 4 (CTLA-4), which play a critical role in T-cell activation and tumor evasion [2]. This evidence concerns the gene CD274 and neoplasm.